SCP-Nano: Revolutionary AI-Powered Technology Visualizes Nanocarriers at Single-Cell Level

Breakthrough in Nanocarrier Visualization

Researchers at Helmholtz Munich, Ludwig-Maximilians-Universität (LMU), and Technical University Munich (TUM) have developed a groundbreaking technology called Single-Cell Profiling of Nanocarriers (SCP-Nano). This innovative method enables the precise detection of nanocarriers throughout the entire mouse body at a single-cell level, marking a significant advancement in the field of targeted drug delivery and gene therapy 1

1

The SCP-Nano Technology

SCP-Nano combines optical tissue clearing, light-sheet microscopy imaging, and deep-learning algorithms to achieve unprecedented precision in visualizing nanocarriers. The process involves:

1. Making whole mouse bodies transparent
2. Three-dimensional imaging of the transparent bodies
3. AI-based analysis to identify and quantify nanocarriers at the single-cell level

This technology can detect nanocarriers in incredibly low doses, down to 0.0005 mg/kg, providing researchers with a new perspective on how these tiny transport vehicles interact with organs and cells 2

2

Applications and Implications

SCP-Nano has been successfully used to analyze various types of nanocarriers, including:

1. Lipid nanoparticles (LNPs)
2. DNA origami structures
3. Adeno-associated viruses (AAVs)

Each of these nanocarriers has unique properties suitable for different applications in modern therapeutics. The research team, led by Ali Ertürk, director of the Institute for Intelligent Biotechnologies (iBIO) at Helmholtz Munich, demonstrated that:

• DNA origami structures can be preferentially targeted to immune cells
• AAV variants target distinct brain regions and adipose tissue
• LNPs carrying mRNA therapeutics can accumulate in heart tissue

These findings highlight the potential of SCP-Nano to detect off-target tissues and associated toxicities before clinical trials, paving the way for safer mRNA therapeutics and other targeted treatments 1

1

Related Stories

Deep Nanometry: AI-Powered Nanoparticle Detection Breakthrough for Early Disease Diagnosis

Virtual mouse uses AI to test nanomedicine without living animals, offering ethical alternative

Moscot: AI-Powered Technology Revolutionizes Cell Tracking in Organ Development

AI and Nanomedicine Breakthrough: Detecting Rare Biomarkers for Prostate Cancer and Atherosclerosis

Driving Innovation in Personalized Medicine

SCP-Nano's ability to precisely identify nanocarrier accumulation and visualize their interactions with target cells is crucial for developing safe and effective nanocarrier applications. Dr. Jie Luo, the study's first author, emphasizes that this technology will not only help assess the safety of existing nanocarriers but also drive the development of new, highly targeted applications 2

2

Future Prospects

The development of SCP-Nano marks an important step toward safer and more effective therapies in fields such as:

1. Cancer treatment
2. Gene therapy
3. Vaccine development

By combining cutting-edge imaging and AI technologies, SCP-Nano offers researchers and clinicians a new level of understanding of how therapies interact with the body. This innovation addresses major challenges in the development of nanocarrier-based technologies and drives the future of precision medicine 1

1

2